NTLA 8-K 2026-08-06

Intellia Therapeutics, Inc. (NTLA) 8-K dated 2026-08-06 — accession 0001193125-26-336772. This URL is the filing, not the NTLA hub.

Intellia Therapeutics, Inc. (NTLA) is a biotechnology company listed on US.

Intellia Therapeutics, Inc. filed a 8-K on 2026-08-06. Accession 0001193125-26-336772.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported NTLA revenue for 2025-12-31 was $67.7M. Net income was -$412.7M. Revenue was up 16.9% from 2024-12-31 to 2025-12-31. NTLA currently screens at market cap $1.19B.

Not investment advice. The NTLA SEC hub lists recent forms. The stock page is the research view.